Artificial intelligence Can Detect genetic disease of the human face
The technology of artificial intelligence (AI, Artificial Intelligence) now plays an important role in the healthcare industry.
The latest, the Central artificial intelligence tested by company health FDNA. This artificial intelligence, able to detect genetic disease symptoms just simply by examining the human face.
The study also reports if the 8 percent of the human population have symptoms should be examined genetic of the face.
In this case, DeepGestalt artificial intelligence capable of detecting Angelman Syndrome, i.e. the symptoms that affect the human nervous system only by examining the shape of a human face, starting from the location of the tooth, the position of the eyes, to the position of the tongue.
"DeepGestalt capable of demonstrating how it works with deep learning algorithms to detect genetic diseases, " says Yaron Gruovich, Chief Technology Officer FDNA.
Gurovich and his team have also been trained DeepGestalt to check facial images of 17,000 patients who are diagnosed have a genetic disease.
In these trials, DeepGestalt able to work more accurately and quickly than clinical experts in examining the patient's face.
In each trial, DeepGestalt unveil the list of diseases in a 91 percent accuracy rate.
Jorge Cardoso, Professor of biomedical school King's College London, admitted if the ability of the DeepGestalt are very elevated.
He also hopes, in the future, DeepGestalt can be used by public hospitals to help detect more types of genetic disease.
"This is one of the fantastic achievement of artificial intelligence that can change human life expectancy. When many people look at artificial intelligence from the negative side, we are thus optimistic DeepGestalt can bring hope for humanity, "he asserts.
Artificial intelligence system back shows tajinya in the field of health.
This time, the artificial intelligence of the Chinese origin who reportedly managed to surpass the capabilities of the doctor's diagnosis.
Xinhua reported, an artificial intelligence system defeated the team of 15 doctoral degrees reputable China in terms of diagnosing a brain tumor and predict the hematoma.
From trials conducted this successful, artificial intelligence mengunguli ability of the doctor when making a diagnosis of the two diseases. Quoted from The Next Web, Wednesday (4/7/2018), artificial intelligence is named BioMind.
The system was developed by Artificial Intelligence Research Centre for Neurological Disorders from Beijing Tiantan Hospital. The time trials, the ability of BioMind turned out to be above average ability of the doctor.
When reviewing a number of cases of brain tumor, BioMind successfully predict correctly about 87 percent. While the doctors are only able to answer correctly 66 percent of the cases are given.
Artificial intelligence is also capable of analyzing the case more quickly. In 15 minutes, BioMind successfully perform diagnosis of 225 cases, whereas the doctors only 30 cases.
When discussing the question of hematoma in the brain, BioMind also managed to answer correctly 83 percent of cases were filed.
As for the doctors can only do diagonsa for 63 percent of cases.
The latest, the Central artificial intelligence tested by company health FDNA. This artificial intelligence, able to detect genetic disease symptoms just simply by examining the human face.
Artificial intelligence Can Detect genetic disease of the human face
Artificial intelligence technology called the DeepGestalt, is expected to help doctors to identify a number of diseases that are difficult to detect with health. So CNN quoted from studies of the journal Nature Medicine, Tuesday (12/3/2019).
The study also reports if the 8 percent of the human population have symptoms should be examined genetic of the face.
In this case, DeepGestalt artificial intelligence capable of detecting Angelman Syndrome, i.e. the symptoms that affect the human nervous system only by examining the shape of a human face, starting from the location of the tooth, the position of the eyes, to the position of the tongue.
"DeepGestalt capable of demonstrating how it works with deep learning algorithms to detect genetic diseases, " says Yaron Gruovich, Chief Technology Officer FDNA.
Already Tested
Gurovich and his team have also been trained DeepGestalt to check facial images of 17,000 patients who are diagnosed have a genetic disease.
In these trials, DeepGestalt able to work more accurately and quickly than clinical experts in examining the patient's face.
In each trial, DeepGestalt unveil the list of diseases in a 91 percent accuracy rate.
Jorge Cardoso, Professor of biomedical school King's College London, admitted if the ability of the DeepGestalt are very elevated.
He also hopes, in the future, DeepGestalt can be used by public hospitals to help detect more types of genetic disease.
"This is one of the fantastic achievement of artificial intelligence that can change human life expectancy. When many people look at artificial intelligence from the negative side, we are thus optimistic DeepGestalt can bring hope for humanity, "he asserts.
Artificial Intelligence: A Doctor When A Diagnosis Of A Brain Tumor
Artificial intelligence system back shows tajinya in the field of health.
This time, the artificial intelligence of the Chinese origin who reportedly managed to surpass the capabilities of the doctor's diagnosis.
Xinhua reported, an artificial intelligence system defeated the team of 15 doctoral degrees reputable China in terms of diagnosing a brain tumor and predict the hematoma.
From trials conducted this successful, artificial intelligence mengunguli ability of the doctor when making a diagnosis of the two diseases. Quoted from The Next Web, Wednesday (4/7/2018), artificial intelligence is named BioMind.
The system was developed by Artificial Intelligence Research Centre for Neurological Disorders from Beijing Tiantan Hospital. The time trials, the ability of BioMind turned out to be above average ability of the doctor.
When reviewing a number of cases of brain tumor, BioMind successfully predict correctly about 87 percent. While the doctors are only able to answer correctly 66 percent of the cases are given.
Artificial intelligence is also capable of analyzing the case more quickly. In 15 minutes, BioMind successfully perform diagnosis of 225 cases, whereas the doctors only 30 cases.
When discussing the question of hematoma in the brain, BioMind also managed to answer correctly 83 percent of cases were filed.
As for the doctors can only do diagonsa for 63 percent of cases.
Komentar
Posting Komentar